WEBSITE BSE:524502 NSE : RAAJMEDISAFE 09 Jul, 11:05
Market Cap ₹120 Cr.
Stock P/E 36.2
P/B 4.5
Current Price ₹91.2
Book Value ₹ 20.4
Face Value 10
52W High ₹122.6
Dividend Yield 0%
52W Low ₹ 63.6
Raaj Medisafe India Limited, founded in 1982 by Mr. Rakesh Agarwal, specializes in the manufacturing of sterilization products and medical disposables. The company offers a wide range of products including sterilization reels, pouches, and wraps, catering to healthcare facilities, hospitals, and clinics. Raaj Medisafe’s clientele includes major healthcare providers and distributors both domestically and internationally. Promoted by Mr. Agarwal and his family, the company has grown to become a trusted name in the medical disposables market. Raaj Medisafe’s mission is to provide high-quality, reliable sterilization solutions that ensure patient safety and infection controls. Raaj Medisafe’s commitment to sustainability, innovation, and ethical practices further enhances their reputation in the healthcare industry.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 10 | 10 | 11 | 11 | 10 | 11 | 11 | 13 | 15 | 24 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
Total Income | 10 | 10 | 11 | 11 | 10 | 11 | 11 | 13 | 15 | 25 |
Total Expenditure | 8 | 8 | 9 | 10 | 9 | 9 | 9 | 11 | 12 | 21 |
Operating Profit | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -1 |
Profit After Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Adjusted Earnings Per Share | 1 | 0.5 | 0.6 | 1 | 0.9 | 0.6 | 0.7 | 0.5 | 0.8 | 2.6 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 2 | 4 | 4 | 5 | 22 | 32 | 35 | 39 | 43 | 63 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 2 | 4 | 4 | 5 | 22 | 32 | 35 | 39 | 43 | 64 |
Total Expenditure | 0 | 1 | 2 | 4 | 4 | 6 | 20 | 28 | 30 | 33 | 37 | 53 |
Operating Profit | -0 | -1 | -0 | -0 | -0 | -1 | 2 | 4 | 5 | 6 | 7 | 9 |
Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | -0 | -0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | -0 | 0 | 0 |
Profit Before Tax | -0 | -1 | -1 | -1 | -1 | -2 | 0 | 3 | 4 | 4 | 4 | 5 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | -1 |
Profit After Tax | -0 | -1 | -1 | -1 | -1 | -2 | -0 | 2 | 3 | 3 | 3 | 6 |
Adjustments | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -0 | -1 | -1 | -1 | -1 | -2 | -0 | 2 | 3 | 3 | 3 | 6 |
Adjusted Earnings Per Share | -1 | -2.4 | -2.2 | -1.7 | -2.8 | -3.2 | -0.6 | 2.1 | 2.8 | 3.1 | 3.1 | 4.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 10% | 10% | 54% | 0% |
Operating Profit CAGR | 17% | 21% | 0% | 0% |
PAT CAGR | 0% | 14% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 1% | 45% | 48% | 25% |
ROE Average | 36% | 70% | 42% | 19% |
ROCE Average | 20% | 24% | 23% | 0% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | -1 | -3 | -4 | -5 | -6 | -8 | -1 | 1 | 4 | 7 | 11 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 4 | 7 | 7 | 8 | 8 | 10 | 8 | 9 | 5 | 7 | 14 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | 0 | 1 |
Total Current Liabilities | 0 | 0 | 2 | 3 | 3 | 3 | 7 | 7 | 10 | 11 | 16 |
Total Liabilities | 3 | 4 | 5 | 6 | 5 | 5 | 14 | 17 | 20 | 26 | 42 |
Fixed Assets | 1 | 3 | 4 | 3 | 3 | 3 | 7 | 7 | 9 | 9 | 11 |
Other Non-Current Assets | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 2 | 12 |
Total Current Assets | 1 | 1 | 2 | 2 | 2 | 2 | 6 | 7 | 10 | 15 | 19 |
Total Assets | 3 | 4 | 5 | 6 | 5 | 5 | 14 | 17 | 20 | 26 | 42 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -1 | -0 | 0 | -0 | -0 | -1 | -1 | 2 | 2 | 0 | 4 |
Cash Flow from Investing Activities | -0 | -2 | -1 | -1 | 0 | -0 | -0 | -3 | -1 | -2 | -13 |
Cash Flow from Financing Activities | 1 | 3 | -0 | 1 | -0 | 1 | 1 | 1 | -1 | 1 | 9 |
Net Cash Inflow / Outflow | 0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.95 | -2.37 | -2.15 | -1.66 | -2.85 | -3.18 | -0.58 | 2.11 | 2.76 | 3.05 | 3.05 |
CEPS(Rs) | -0.57 | -1.87 | -1.68 | -1.11 | -2.22 | -2.57 | 0.77 | 2.76 | 3.43 | 3.74 | 3.82 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -2.98 | -5.9 | -8.05 | -9.75 | -12.62 | -15.79 | -14.16 | 0.98 | 3.81 | 6.87 | 9.94 |
Core EBITDA Margin(%) | 0 | 0 | -16.76 | -2.03 | -9.8 | -16.52 | 6.86 | 12.65 | 14.44 | 14.53 | 15.3 |
EBIT Margin(%) | 0 | 0 | -29.6 | -7.24 | -16.32 | -17.38 | 5.34 | 10.46 | 12.61 | 12.64 | 13.54 |
Pre Tax Margin(%) | 0 | 0 | -59.08 | -18.65 | -30.46 | -32.67 | 0.08 | 8.14 | 10.58 | 9.77 | 9.92 |
PAT Margin (%) | 0 | 0 | -59.08 | -18.65 | -30.46 | -32.67 | -1.31 | 7.15 | 8.55 | 8.62 | 7.7 |
Cash Profit Margin (%) | 0 | 0 | -45.98 | -12.53 | -23.78 | -26.35 | 1.76 | 9.36 | 10.6 | 10.57 | 9.63 |
ROA(%) | -21.3 | -33.33 | -22.4 | -15.08 | -26.04 | -30.95 | -3.09 | 15.23 | 16.63 | 14.67 | 9.89 |
ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115.41 | 57.21 | 36.32 |
ROCE(%) | -20.12 | -24.25 | -13.98 | -8.33 | -21 | -24.82 | 16.3 | 27.03 | 28.33 | 24.24 | 19.58 |
Receivable days | 0 | 5621.18 | 63.84 | 41.1 | 47.01 | 59.52 | 45.82 | 54.52 | 53.58 | 58.09 | 63.16 |
Inventory Days | 0 | 4327.33 | 36.4 | 47.39 | 59.76 | 46.17 | 11.92 | 13.58 | 23.98 | 45.92 | 63.61 |
Payable days | 0 | 3205.19 | 301.47 | 235.65 | 243.81 | 173.66 | 39.91 | 27.97 | 12.86 | 8.23 | 9.31 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.55 | 14.15 | 7.65 | 17.71 |
Price/Book(x) | 0 | -1.82 | -1 | 0 | 0 | 0 | 0 | 14.04 | 10.27 | 3.4 | 5.44 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0 | 2862.72 | 6.46 | 3.56 | 3.58 | 3.46 | 0.77 | 0.89 | 1.6 | 1.06 | 1.96 |
EV/Core EBITDA(x) | -52.92 | -22.24 | -39.05 | -367.08 | -31.78 | -21.17 | 9.04 | 6.89 | 10.88 | 7.29 | 12.67 |
Net Sales Growth(%) | 0 | 0 | 0 | 119.06 | 2.29 | 19.11 | 354.37 | 45.92 | 9.08 | 11.32 | 11.98 |
EBIT Growth(%) | -5.03 | -91.43 | 34.06 | 40.33 | -137.07 | -10.88 | 238.47 | 186.77 | 32.08 | 9.87 | 19.96 |
PAT Growth(%) | -13.44 | -149.28 | 9.09 | 22.98 | -71.72 | -11.7 | 81.86 | 895.98 | 31.02 | 10.52 | -0.04 |
EPS Growth(%) | -13.43 | -149.28 | 9.13 | 22.98 | -71.72 | -11.7 | 81.85 | 465.36 | 31.03 | 10.51 | -0.04 |
Debt/Equity(x) | -2.75 | -2.4 | -1.89 | -1.85 | -1.49 | -1.47 | -1.68 | 12.25 | 3.14 | 2.08 | 2.39 |
Current Ratio(x) | 8.7 | 2.98 | 0.86 | 0.63 | 0.49 | 0.5 | 0.94 | 1.12 | 1.05 | 1.34 | 1.16 |
Quick Ratio(x) | 8.48 | 2.78 | 0.71 | 0.31 | 0.3 | 0.33 | 0.81 | 0.89 | 0.73 | 0.76 | 0.64 |
Interest Cover(x) | -8.96 | -2.23 | -1 | -0.63 | -1.15 | -1.14 | 1.01 | 4.52 | 6.22 | 4.4 | 3.74 |
Total Debt/Mcap(x) | 0 | 1.32 | 1.88 | 0 | 0 | 0 | 0 | 0.87 | 0.3 | 0.61 | 0.44 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 73.45 | 73.45 | 73.45 | 73.45 | 73.45 | 73.45 | 73.45 | 73.44 | 73.44 | 73.44 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 26.55 | 26.55 | 26.55 | 26.55 | 26.55 | 26.55 | 26.55 | 26.56 | 26.56 | 26.56 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.97 | 0.97 | 0.97 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.35 | 0.35 | 0.35 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.32 | 1.32 | 1.32 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About